Skip to Content

SurgLine International Inc SGLN

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SGLN is trading within a range we consider fairly valued.
Price
$0.00
Fair Value
$8.94
Uncertainty
Extreme
1-Star Price
$6.59
5-Star Price
$3.83
Economic Moat
Jckddw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SGLN is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
/
Market Cap
$5,690.12
Volume/Avg
101,000 / 450,500

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

SurgLine International Inc provides medical and surgical products at discount prices. The company mainly offers Spine products, Trauma products, endoscope products, and Medical Disposables. Spine line products include: pedicle screws, plates, rods, hooks, cages and biologics. Trauma products include: surgical instruments and surgical sets for hand, foot, hips, small fragment and more. Endoscope products include a Range of Endoscopes. Medical Disposables include: Single use surgical supplies, and medical disposables.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Total Number of Employees
5

Valuation

Metric
SGLN
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
SGLN
Quick Ratio
0.05
Current Ratio
0.06
Interest Coverage
−8.91
Quick Ratio
No chart available

Profitability

Metric
SGLN
Return on Assets (Normalized)
−507.36%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesCwtjfmwmVpdhb$189.3 Bil
SYK
Stryker CorpCdfqdzcnxHsmq$130.1 Bil
MDT
Medtronic PLCJygqhpmkTjmnkjl$109.3 Bil
BSX
Boston Scientific CorpCjnlhhpNqgtkv$100.9 Bil
EW
Edwards Lifesciences CorpQcylnfwrhtSvmmks$54.3 Bil
DXCM
DexCom IncYtfpwltrdByqr$54.1 Bil
ZBH
Zimmer Biomet Holdings IncYgtqbnybkzPlyjj$25.6 Bil
ALGN
Align Technology IncZqsmmvtlRxlcww$24.7 Bil
PHG
Koninklijke Philips NV ADRDtrhpmdgFyyqkdr$18.8 Bil
PODD
Insulet CorpNgxgmxdljwNdsvvnj$12.3 Bil

Sponsor Center